Bionano Genomics (BNGO) vs Cuprina (Cayman) (CUPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bionano Genomics (BNGO) has outperformed Cuprina (Cayman) (CUPR) over the past year, losing 26.3% versus a loss of 80.4%. Bionano Genomics is the larger company by market cap ($16.9 million vs $11.8 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNGO | CUPR |
|---|---|---|
| Share price | $1.44 | $1.69 |
| Market cap | $16.90M | $11.84M |
| 1-day change | -1.71% | -11.05% |
| YTD return | -4.58% | -47.19% |
| 1-year return | -26.26% | -80.44% |
| 5-year return | -99.95% | — |
| EPS (TTM) | $-3.02 | $-1.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.23 | $14.80 |
| 52-week low | $1.00 | $1.45 |
| Distance from 52-week high | -35.65% | -88.58% |
| Analyst consensus | none | — |
| Avg. price target upside | +248.43% | — |
| Average volume | 921.59K | 94.31K |
| Shares outstanding | 11.78M | 5.24M |
| Employees | 95 | 10 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BNGO has outperformed CUPR by 54.2 percentage points over the past year.
- The two companies sit in different sectors: Bionano Genomics in Industrials and Cuprina (Cayman) in Health Care.
About Bionano Genomics
BNGO stock →Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
Industrials · Biotechnology: Laboratory Analytical Instruments · 95 employees
About Cuprina (Cayman)
CUPR stock →Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name.
Health Care · Industrial Specialties · 10 employees
BNGO vs CUPR FAQ
Which is bigger, Bionano Genomics or Cuprina (Cayman)?
Bionano Genomics (BNGO) is larger, with a market capitalization of $16.90M compared with $11.84M for Cuprina (Cayman) (CUPR).
Which stock has performed better over the past year, BNGO or CUPR?
BNGO returned -26.26% over the past 12 months, compared with -80.44% for CUPR (price return, excluding dividends). Past performance does not predict future results.
Are Bionano Genomics and Cuprina (Cayman) in the same industry?
No. Bionano Genomics is in the Industrials sector, while Cuprina (Cayman) is in Health Care.